August 20, 2012
RIBOMIC Inc. (Minato-ward, Tokyo), a biopharmaceutical venture created by Tokyo University’s Institute of Medical Science, announced on August 17 that it has acquired a substance patent for an analgesic agent containing its investigational RNA aptamer. The company will seek development...read more